X

Xenon Pharmaceuticals
D

XENE

40.740
USD
-0.46
(-1.12%)
مغلق
حجم التداول
35,303
الربح لكل سهم
-5
العائد الربحي
-
P/E
-11
حجم السوق
3,141,290,251
أصول ذات صلة الأخبار المقالات

العنوان: Xenon Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.